Abstract : The D-p-hydroxyphenylglycine (D-HPG) production process from DL-5-p-hydroxyphenylhydantoin by a combination of two immobilized enzymes, hydantoinase and N-carbamoyl-D-amino acid amidohydrolase (DCase), was established. A hydantoinase obtained from a thermophilic bacterium and a DCase from a mesophilic bacterium improved the thermostability by a protein engineering technique. The latter enzyme could be used over 700 times as a bioreactor. An enzymatic reduction system was developed to produce optically active alcohols from the corresponding carbonyl compounds. Effective production of ethyl (S)-4-chloro-3-hydroxybutyrate was achieved by the use of the recombinant Escherichia coli that was co-harbored in the genes of a carbonyl reductase (S1) from Candida magnoliae and glucose dehydrogenase from Bacillus megaterium, in high productivity (350 g/l, over 99% e.e.). Successful change in the cofactor dependency of S1, from NADPH to NADH, was accomplished highly efficiently by the use of in silico screening.
Next, the DCase gene was mutagenized in vitro randomly with hydroxylamine hydrochloride or NaNO2, followed by the selection of the DCase that increased its thermostability.4,5 The recombinant E. coli with the mutagenized DCase gene was screened by means of a high-throughput method, i.e., a colorimetric colony assay method, by which colonies producing mutagenized DCase with improved thermostability could be selected by detection of the remaining DCase activity after heat treatment (65 , 5 min). This was based on the generation of coloring matter by the coupling reaction with DCase, D-amino acid oxidase and peroxidase. After assaying about 34,000 colonies, we confirmed that 16 clones had high thermostability and showed no reduction of crude extract activity.4 From the sequence analysis of the DCase genes of the selected clones, it became apparent that at least one of the nucleotides of the DCase gene had been changed. The amino acid changes related to the increase of thermostability proved to be caused by the changes of the 57th amino acid from His to Tyr, the 203rd amino acid from Pro to Ser or Leu, and the 236th amino acid from Val to Ala. The thermostable temperature, which was a parameter of thermosta- Figure 4 shows schematics of the enzyme-substrate interaction of the complex with CD-Met. Substrate specificity could be attributed to the two major interactions. One is the direct contact of the carbamoyl group of a substrate with the catalytic residues Glu46, Lys126 and Cys171, which is replaced by Ala and not shown. The second is the interaction of the carboxyl moiety of a substrate with the side chains of Arg174 and Arg175 to maintain a stable binding platform. On the basis of DCase structures, we propose a mechanism of enzyme reaction that assumes the general base activation of the thiol group of Cys171 by the carboxyl group of G1u46, nucleophilic attack on the amide carbon of a substrate, stabilization of a tetrahedral intermediate by the E-amino group of Lys126, formation of an acyl-enzyme complex and deacylation of the enzyme by a nucleophilic attack of a water molecule through the same general base/acid mechanism.
As mentioned above, the three-dimensional structures of DCase provide detailed explanations of the DCase's thermostable properties and biological functions. Furthermore, they provide the framework for rationally designing valuable mutants for industrial use.
Enzymatic Reduction System
The asymmetric reduction of prochiral carbonyl compounds is an attractive methodology for synthesizing optically active alcohols. Therefore, many trials were done to develop effective methodologies in the fields of both organic chemistry and biological chemistry.
Concerning the biological method, there are numerous reports of reduction of carbonyl compounds using baker's yeast as the catalyst.11 Baker's yeast is easily available and inexpensive and does not require a fermentation procedure, which is unfamiliar to organic chemists. But whole microbial cells, such as baker's yeast, are used mostly in the laboratory, because the reaction mechanism has not been clearly understood and the productivity of the reaction is quite low. In general, most microorganisms have several kinds of reducing enzymes with different stereospecificity in their cells, so it is difficult to obtain alcohol with high optical purity by using whole microbial cells as the catalyst.
Biological reduction might involve two enzyme systems. One is carbonyl reductase or alcohol dehydrogenase catalyzing the asymmetric reduction of carbonyl compounds. These enzymes require an expensive cofactor, NADH (reduced nicotinamide adenine dinucleotide) or NADPH (reduced nicotinamide adenine dinucleotide phosphate), as an electron donor. The othcr is a cofactor regeneration which system reduces NAD(P)+ to NAD(P)H. As a whole microbial cell contains both enzyme systems in the same cell, the cofactor of the reduced form might be regenerated through the oxidation of the energy source such as carbohydrate or ethanol. The reduction activity on whole cells is often very weak because the activities of these related enzymes are not very high and the substrate or the product inhibits the enzymes. In addition, because the mechanism of cofactor regeneration in microbial cells is complicated, it is difficult to establish the optimum reaction conditions. The low performance has resulted in little industrial application of this methodology, although many microorganisms have the ability to reduce various carbonyl compounds.
We tried to construct an "enzymatic reduction system" for industrial production of various kinds of optically active alcohols. The system was realized by our finding a tough reductase for carbonyl compounds and by overproducing two enzymes, a carbonyl reductase and a cofactor regeneration enzyme, in the same E. coli cells by use of the recombinant DNA techniques.
Carbonyl Reductase
Optically active 3-hydroxyacid esters are promising building blocks for asymmetric organic synthesis. The asymmetric reduction of 3-ketoesters might be a more economical way to synthesize chiral 3-hydroxyacid esters because the reaction is stoichiometric and the substrate is easily synthesized. The organometallic asymmetric hydrogenation of ethyl 4-chloro-3-oxobutanoate (COBE) to ethyl 4-chloro-3-hydroxybutanoate (CHBE) is an excellent method, but it requires high hydrogen pressure12.
Many studies have been reported on the biological reduction of COBE to (R)-CHBE, which can be converted to L-carnitine. S. Shimizu et al. reported that the combination of an aldehyde reductase from Sporobolornyces salmonicolor and a coenzyme-regenerating system containing glucose dehydrogenase allowed the accumulation of 300 g/1 of (R)-CHBE13 used for L-carnitine synthesis.14 On the other hand, (S)-CHBE is a more useful starting material for synthesis of HMG-CoA reductase inhibitors.15 The whole cells of Geotrichum candidum reported by K. O. Hallinan et a/. 16 and Zygosaccahrornyces rouxii reported by R. N. Patel et al.17 produced 5 g/l and 13 g/l of (S)-CHBE, respectively. The whole cells of Candida magnoliae accumulated 90 g/l of (S)-CHBE with 96.6% e.e. with the two-phase coenzymeregenerating system containing glucose in water/butyl acetate. This useful yeast strain could be found by unique screening procedures such as the use of heated microbial cells or the addition of an organic solvent to the reaction mixture.18 The two-phase reaction system is advantageous in a bioreaction because of the protection against the degradation of unstable substrates in the aqueous phase and the inactivation of the enzyme by toxic substrates or products.
C . magnoliae has multiple COBE-reducing enzymes, three of which were isolated and characterized.19 NADPH-dependent carbonyl reductases (S1, S4) catalyze the reduction of COBE to (S)-CHBE (over 99% e.e., 51% e.e., respectively), and an NADPH-dependent aldehyde reductase (R) catalyzes the reduction of COBE to optically pure (R)-CHBE. The amounts of these three enzymes in the yeast cells are similar, but the specific activity of S4 with COBE (74.0 units/mg) is highet than that of Si (13.5 units/mg) or R (12.2 units/mg), and S4 has a Km value for COBE (0.11 mM) that differs from that of Si or R (4.6 mM, 2.9 mM, respectively). The deduced amino acid sequence of Si shows significant similarity to those of members of the short-chain dehydrogenase/reductase superfamily. 20 The physiological roles of these enzymes in the yeast cells are not known (Tables 5, 6 ).
Genes encoding carbonyl reductase Si were cloned and expressed successfully in E. coli cells by Y. Yasohara el al. 2° The existence of some COBE-reducing enzymes with different stereoselectivities lowered the optical purity of (S)-CHBE. Cloning and overexpression of the gene encoding the only required enzyme, Si, with high stereoselectivity is a powerful tool to overcome this problem. The other problem to solve before we can achieve effective enzymatic reduction is regeneration of the reduced-form coenzyme. Enzymatic regeneration is a convenient method, and two dehydrogenases are especially well known. 21 formic acid to carbon dioxide with reduction of NAD+ to NADH. Glucose dehydrogenase oxidizes glucose into gluconolactone with reduction of NAD(P)+ to NAD(P)H, and gluconolactone is converted to gluconic acid spontaneously. These enzymes are useful regenerators of a reduced-form cofactor because the substrates are inexpensive and the reactions are irreversible. N. Kizaki et al. constructed an E. coli transformant carrying a plasmid vector containing both the gene coding Si and the gene coding glucose dehydrogenase (GDH). 22 The gene coding GDH was cloned from a bacterium, Bacillus megaterium. The plasmid vector containing these two enzymes was constructed and introduced to E. coli cells. E. coli cells which overproduces these two enzymes is an effective catalyst for COBE-reduction (Scheme 2). For example, in the water/organic solvent two-phase system, 350 g/1 of (S)-CHBE was accumulated in the organic phase ( Figure 5) , with an 85% molar yield. In the aqueous mono-phase system, 208 g/1 of (S)-CHBE was accumulated by continuously feeding on COBE, which is unstable in the aqueous phase. In this case, the calculated turnover number of NADP+ to CHBE was 21,600 mol/mol. The optical purity formed was over 99% e.e. in both systems. 22 The aqueous system is very simple and clean. The E. coli transformant co-producing carbonyl reductase and GDH is a useful catalyst for the synthesis of various optically active 3-hydroxyacid ester derivatives (Table 7) .23 Table 5 .
Properities of COBE-reducing enzymes in Candida magnoliae Table 6 . Substrate specificity of COBE-reducing enzymes in Candida magnoliae Scheme 2. Enzymatic reduction system for (S)-CHBE production by E. coli transformant co-producting carbonyl reductase and glucose dehydrogenase secondary alcohol dehydrogenase (AFPDH) was purified and characterized from C. maris. This enzyme catalyzes both the reduction of carbonyl compounds and the oxidation of hydroxyl compounds and has broad substrate specificity and excellent stereoselectivity. The deduced amino acid sequence of AFPDH shows significant similarity to those of members of the short-chain dehydrogenase/reductase superfamily. E. coli transformant co-producing AFPDH and GDH was easily constructed in a similar manner as that used to construct the transformant co-producing Si and GDH. The 51 gene could be substituted by the AFPDH gene on the plasmid vector, and this vector was transformed to E. coli. This transformant is a useful catalyst for the synthesis of various optically active compounds such as pyridineethanol derivatives, 3-hydroxyacid esters and various secondary alcohols (Table 8 ). 3.3 Reductase Library E. coli tansformant co-producing a reducing enzyme and a cofactor-regenerating enzyme is a useful catalyst for the synthesis of optically active hydroxyl compounds from carbonyl compounds. This biocatalyst is easily prepared if we have a gene coding a reducing enzyme. In general, the substrate specificity of a reducing enzyme is not so broad. Therefore, it is necessary to have various types of useful enzymes that are applicable to various compounds. An example of reducing enzymes in our library and the products they typically synthesize are shown in Table 9 .
Modification of Coenzyme Specificity in Carbonyl
Reductase S1 In previous studies, we used GDH as a cofactor-regenerating enzyme. Though GDH can regenerate both NADH and NADPH, this enzyme produces the equivalent of gluconic acid as a by-product. On the other hand, formate dehydrogenase (FDH) is also useful as a regenerating enzyme of a cofactor, but FDH preferably interacts only with NADH. Therefore, FDH is not able to couple with a NADP-dependent carbonyl reductase such as carbonyl reductase Sl. However, there are several advantages to employing FDH in an enzymatic reduction system, because NADH is less expensive than NADPH, and the resulting by-product is carbon dioxide only to recycle NAD+ to NADH25, so we attempted modification of coenzyme dependency in carbonyl reductase Si from NADPH specific to NADH (Scheme 3).
Several successful mutations and redesigns to exchange the coenzyme specificity of dehydrogenase or reductase that uses nicotinamide coenzyme have been reported: glutathione reductase and dihydrolipoamide dehydrogenase (flavoprotein disulphide oxidoreductase family)26, isocitrate dehydrogenase and isopropylmalate dehydrogenase (decarboxylating dehydrogenase family)27, lactate dehydrogenase28 and leucine dehydrogenase29. Those results were obtained using empirical design methods that were derived from the minute and detailed analysis of their amino acid sequences (one-dimensional (1D)-structure) and/or their atomic coordinates determined by X-ray analysis (three-dimensional (3D)-structure).
Considering those empirical design methods and knowledge, we introduced a rational design method on the basis of the 3D-structure of proteins and ligands3° to redesign the coenzyme specificity of carbonyl reductase S 1. This design method is an in silico screening method, and it is composed of semi-automatically computational processes of (1) generation of mutant protein sequences from a template (wild-type) protein sequence, (2) modeling three-dimensional structures of generated mutants with a dead-end elimination algorithm and (3) evaluation of free energy differences in the ligand-binding (here, coenzyme-binding) processes between those mutants by calculating roughly the molecular mechanics potential energy including the solvation energy term31. The evaluated binding free energy differences showed good correlation to kinetic parameter Km, the dissociation constant, between the enzyme and coenzyme. Here, the amino acid residue positions to mutate were limited to neighbors of adenosine f-phosphate (in NADPH) or f-OH (in NADH) of the coenzyme ( Figure 6 ).
Next, we performed in silico screening to search for reductase mutants with lower coenzyme-binding energy to NADPH and higher coenzyme-binding energy to NADH. The resulting estimation of the coenzyme-binding energy of virtual carbonyl reductase Si mutants is shown in Figure 7 . Several preferable mutant sequences were selected according to the calculated coenzyme-binding energy, and also with consideration of the thermostability and chemical stability to reactants (robustness to halo-chemicals such as COBE) of the mutants.
The selected mutants were obtained by site-directed mutagenesis to the wild-type Si enzyme, and the resulting specific activity of mutated enzymes is shown in Table 10 . The designed mutants showed NADH dependency and lost ability to utilize NADPH as a coenzyme, although the substrate specificity remained unchanged. The results of asymmetric reduction of COBE to (S)-CHBE by the designed mutant, S1M4 enzyme and NADH are shown in Figure 8 , cooperating with the NADH reproduction system of FDH32 and formate. The specific activity of S1M4 enzyme was rather lower than that of wild-type Si enzyme; however, S1M4 enzyme had as many catalytic properties applicable to Scheme 3. Enzymatic reduction system for (S)-CHBE production by mutated carbonyl reductase Si (S1M4) and FDH A complex structure of carbonyl reductase S1 and NADPH created by homology modeling from the X-ray structure of a NADP-dependent mannitol dehydrogenase (1H5Q in Protein Data Bank) was shown. NADPH molecule was represented as CPK, and the eight residues to be mutated in calculation, position number 41-43 and 63-66 were represented as ball-and -stick. used as a reactor for over a year without requiring change. This bioreactor system is more environmentally friendly and saves resources. Our second goal was to establish an enzymatic reduction system. We hoped to establish a general methodology for the production of optically active alcohols. Our first trial was the development of the process for (S)-CHBE coupled with COBE reductase and GDH as the regenerating enzyme of NADPH, in collaboration with S. Shimizu and his members. The point of this study was to find an enzyme with tolerance to a given substrate and product, and with stereo-selectivity on the reaction. We found a suitable enzyme, named S1, in C. magnoliae. Owing to the Si enzyme, we achieved high productivity of (S)-CHBE (350 g/l, over 99 % e.e.). Since the industrial production of (S)-CHBE started, we have searched for other reductases and dehydrogenases to use with other substrates and with other stereo-specificities.
Next, we tried to change the cofactor dependency of carbonyl reductase Si with the computer-aided design , and succeeded in obtaining several mutants that act with NADH and not with NADPH. The satisfactory mutant, S1M4, was found in only 9 mutated enzymes. This success shows the possibility of various combinations of carbonyl reductase or alcohol dehydrogenase and GDH or FDH. The reaction scheme with a water-organic two-phase asymmetric reduction system cooperating with the coenzyme regeneration system was shown at the upper figure. The reactant COBE and product CHBE were in an organic layer, and the enzymes and coenzyme (S1M4-FDH/NADH) were in a water layer. The reaction profiles as the concentration of the product CHBE was shown at the lower figure.
Figure 8. Synthesis of (S)-CHBE by mutated carbonyl reductase S1 (S1M4). 
